American Development Investment Fund, Inc. (1096935) SEC Filing 10-Q Quarterly report for the period ending Wednesday, June 30, 2010

American Biocare, Inc.

CIK: 1096935

View differences made from one quarter to another to evaluate American Biocare, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Biocare, Inc..


Assess how American Biocare, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Biocare, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1096935
Form Type: 10-Q Quarterly Report
Accession Number: 0001096935-10-000004
Submitted to the SEC: Fri Aug 13 2010 5:03:50 PM EST
Accepted by the SEC: Fri Aug 13 2010
Period: Wednesday, June 30, 2010
Industry: Investors

External Resources:

Bookmark the Permalink: